PEN Q4 2023 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$285M+28.7% YoY

Gross Profit

$187M65.7% margin

Operating Income

$35M12.3% margin

Net Income

$54M19.0% margin

EPS (Diluted)

$1.38

QoQ Revenue Growth

+5.1%

Cash Flow

Operating Cash Flow

$36M

Free Cash Flow

$33M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$377M

Stockholders' Equity

$1.2B

Cash & Equivalents

$167M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$285M	$221M	+28.7%
Gross Profit	$187M	$138M	+35.1%
Operating Income	$35M	$5M	+624.8%
Net Income	$54M	$4M	+1298.5%

Geographic Segments

UNITED STATES

$204M72%

Other Non-US

$81M28%